The examples set out below have been chosen toillustrate particular aspects of dose calculation. It has been necessary to make assumptions about the biological behavior of the radiopharmaceuticals considered and to set up models; while an attempt has been made to render these plausible, some simplifications have been necessary and the results will, of course, only apply to the assumed model. The aim has been to illustrate the methods outlined in this report.
As the ICRU wishes to encourage the use of SI units, they have been used in the calculations; the improved consistency and simplicity become apparent as examples are worked out. Initially the magnitude of some of the quantities will be unfamiliar to those accustomed to the units in use for many years: the gray differs by two orders of magnitude from the rad, and the becquerel is a very small quantity of activity compared to the curie.
No tabulations of appropriate data have yet been made using SI units. The values used here have, therefore, been derived by applying the appropriate conversion factors.
Much use is made of the tables of absorbed fractions published by Snyder et al. (1969) in MIRD Pamphlet No. 5 . It is to be noted that these tables refer to a "standard man". Absorbed fractions for subjects of appreciably different body sizes (particularly children) may be substantially different. It may then be more accurate to assume a different anatomical model and derive values of</> from tables or graphs relating to ellipsoids or use data for specific absorbed fractions <I> (see Appendix B).
Example 1: 24 Na in ionic form, oral or intravenous
This example illustrates a very simple distribution and a simple retention function relating to a radionuclide with an uncomplicated decay scheme.
Biological assumptions. Assimilation from the gastrointestinal tract is complete and rapid compared with the rate of radioactive decay. Distribution is uniform throughout the body and the whole-body mean dose is required. The biological half-life is long compared with the physical half-life, so that the latter can be taken as the effective half-life.
Physical assumptions. The physical half-life is 15.0 h. As the retention is represented by a single exponential function, the mean life is 1.44 times the half-life and, therefore, equals 21.6 h, or 7.8 X 10 4 s. Energies and abundance of the different radiations are taken from Dillman and Von der Lage (1975) , or .J is taken from Appendix A. Absorbed fractions are from Snyder et al. (1969) . The calculations are for a standard man, mass 70 kg.
Calculations. The calculations are set out in 
Example 2: Intravenous administration of 9 9Tcm sulphur colloid
It is required to calculate the dose to the liver and to the female gonads.
Biological assumptions. The liver has a mass of 1.833 kg and the ovaries have a mass of 0.0088 kg (the values used in calculations of absorbed fraction in Snyder et al., 1969) .
85% of the activity remains in the liver with an effective half-life of 6 hours (equal to the physical halflife). Initial blood clearance and liver uptake are rapid compared with the decay. The remaining 15% of the activity is localized in other parts of the reticulo-endothelial system and does not contribute significantly to the irradiation of the organs considered.
Physical assumptions. Values of the radiation energies, Ei, the abundances, ni, mean energies per nuclear transformation, Lli and half-life are from the (1969) .
The abundance of the 143 keV (2.29 X 10-14 J) yray is very low and this radiation is, therefore, neglected.
In calculating the absorbed dose to the liver, the K x rays are considered to be penetrating, as more than 10% of the radiation emitted within the liver escapes from it. However, the x rays can be neglected in considering the dose to the ovaries.
As all the nonpenetrating radiation has an absorbed fraction of unity, the individual values of .di can be collected together before insertion into Table C-2. The radiation to be picked out from tables of values of .di includes the internal conversion electrons, the Auger electrons and the L x rays. This selection has already been made in Table A-IV in Appendix A . Snyder et al. (1969) do not give values of absorbed fractions for liver as the source and the ovaries as the target. However, figures are supplied for the converse, so use can be made of the reciprocity principle. As described in Section 2.4.3, this states that the specific absorbed fraction is independent of which region is designated source and which target. Snyder et al. (1969) give a numerical value of 0.0037 for the ovaries as the source and the liver as target, i.e., a specific absorbed fraction of (0.0037 /1.833)kg-1 • The absorbed fraction for liver as source and ovaries as target is therefore 0.0037 X 0.0088/1.833 = 1.8 X 10-5 .
Alternatively, use can be made of point isotropic specific absorbed fractions (Berger, 1968) given in Figure B .1 of Appendix B. It is assumed that the liver acts effectively as a point source 25 cm from the ovaries. The corresponding specific absorbed fraction is 2.5 X 10-6 g-1 , and absorbed fraction 2.2 X 10-5 .
Calculations. For an administration of 1 Bq A = 1 x 6 x 3600 x 1.44 x 0.85 = 2.64 x 10 4 Bq s
The Ka and K13 x rays could have been considered together with a common value of ¢i with no loss of accuracy.
Calculations in alternative units. In order to illustrate the use of the units adopted most widely hitherto, the foregoing calculation is repeated. The sources of data are the same, conversion factors being unnecessary. With absorbed dose in millirad, activity in microcuries (µCi), mean energy in kiloelectronvolts (ke V), time in hours (h), mass in grams (g), .di= 2.13 niEi.
The time integral of activity for an administration of 1 µCi,
The dose calculations are set out in Table C 
Example 3: 9 9 Tcm-fabelled macroaggregated albumin injected intravenously for lung scanning
In addition to the straightforward calculation of mean dose to the lung tissue, an estimation is made of the dose absorbed in the immediate vicinity of a radioactive particle.
Biological assumptions. The mass of the lungs is taken as 1 kg (Snyder et al., 1969) . The changes with time of activity per unit mass are taken from measurements made with 1 3 1 I-labeled macroaggregated albumin by Furth et al. (1965) but are typical of those quoted in other papers. Data for 99 Tcm-labelled macroaggregated albumin could not be found, but it is assumed that the different label does not alter the biological behavior in the lungs during the short period concerned. 87% of the injected activity is cleared from the blood very rapidly by the lungs. The remaining 13% is not considered to contribute appreciably to the lung radiation dose. The disappearance of activity from the lungs is by a double exponential process, 88% clearing with a biological half-life of 6 hours and 12% with a half-life of 77 hours. The 99Tcm, once removed from the lungs, is excreted quickly and contributes no more to the lung dose.
Physical assumptions. As in previous examples, values of half-life, Ei, ni and .di are taken from Dillman and Von der Lage (1975) or Appendix A and the absorbed fractions again come from Snyder et al. (1969) . It is to be noted that the density of lung tissue is much less than unity. This has been taken into account in the calculations in Snyder et al. (1969) . However, if ab- sorbed fractions are obtained from general tables or graphs such as those in Appendix B, a density correction is necessary (see Section 2.4.9).
To illustrate the use of these general data, each lung is considered to be a thick ellipsoid of mass 500 g and density 0.3 g cm-3 . The density transformation rule states that the absorbed fraction corresponding to a mass min the medium of density 1 g cm-3 will correspond to a mass of mp-2 in a medium of density pg cm-3 . The corresponding mass for a lung in a medium of density 1 g cm-3 is therefore 45 g. Extrapolation of the absqrbed fraction data of Brownell et al. (1968) given in Figure B . 7, by the method outlined in Appendix B, gives ¢ = 0.043. A backscatter correction factor of 1.2 is derived from Figure B .8, although it is doubtful whether the full calculated backscatter is obtained in the thorax. A final absorbed fraction of 0.052 is obtained, not too dissimilar from that derived from Snyder et al. (1969) and used in the calculations in Section 3.3.
Calculations. The irradiation of one lung from activity in the other lung is ignored in these calculations.
The activity, A, in the lungs at time tis given by
where Ao is the administered dose, 0.87 the fraction trapped in the lungs, ;\ 1 the disappearance constant relating to the biological fate of 88% of the lung activity (= 0.693/T1;2 = 0.693/6 h-1 ), ,\ 2 the disappearance constant relating to the remaining 12% of the activity (= 0.693/77 h-1 ) and,\ the physical decay constant(= 0.693/6 h-1 ). A is obtained by integration of Eq. (C.3-1), or by considering the effective mean lives of the two fractions. Thus, the effective half-life of the fast component is 1/(1/6 + 1/6) = 3 hours, and the mean life is interest to calculate the local absorbed dose in the capillary endothelium from individual labelled particles and compare it with the mean absorbed dose calculated above.
It is assumed that the diameter of a particle is 30 µm, and that it is of density 1 g cm-3 . A total quantity of 14 mg of albumin (0.2 mg kg-1 body weight) is in the lungs. The mass of a particle is 1.5 X 10-s g and the number of particles 14 X 10-3 /1.5 X 10-s ~ 10 6 . If 1 Bq of 99Tcm is in the lungs, activity per particle is 10-6 Bq.
Most of the energy absorbed locally comes from the internal conversion electrons. These have an energy of about 120 keV and, therefore, a 90% radius in tissue of density 1 g cm-3 of about 0.2 mm. It is therefore reasonable to consider a local volume of radius 0.2 mm around the particle. With a mass of 3.34 X 10-5 g, Lli for the nonpenetrating radiation is still 2.77 X 10-1 5 J, as in Table C -4 and the absorbed fraction, ¢, is 1.
The significance of the gamma-ray dose absorbed in this small volume can be assessed by using the pointsource function of Berger (Appendix B, Figure B .2). The specific absorbed fraction at 0.02 cm for the 140-keV gamma ray obtained from the graph is 0.002/(0.02) 2 = 5 g-1 and the absorbed fraction 5 X 3.34 X 10-5 = 1.7 X 10-4 . Although the mean energy of the gamma radiation emitted by the particle is some 7 times that of the nonpenetrating radiation, the much lower absorbed fraction means that the former can be ignored by comparison.
In the dose equation for the small sphere, D = ALli¢Jm, Lli = 2.77 x 10-15 J Bq-1 s-1 , ¢i = 1, A = 1.49 X 104 x 10-6 Ao Bq s, m = 3.34 X 10-s kg, so that D = 1.2 X 10-9 Gy for 1 Bq administered. It is to be noted that this locally absorbed dose is much higher than the mean lung dose calculated in Table C -4 . This is to be expected, as the total mass of all the one million small spheres considered is only about one thirtieth of the lung mass, while the absorbed energy is not much below that for the whole organ.
Example 4: Intravenous injection of 51 Cr-labelled red cells
When compatible 51 Cr-labelled red cells are injected intravenously, they remain in the circulation for a considerable time. As labelling is random, there is a In addition, slow elution of the chromium from cells and physical decay of the 51 Cr lead to an accelerated reduction of blood activity. There is clearly an interest in the calculation of blood dose. On the death of the cells, they are principally removed from the circulation by the spleen, and the chromium remains in that organ for an appreciable time. The absorbed dose for the spleen is, therefore, of importance.
In addition, a calculation of the mean absorbed dose for the whole body is desired.
The calculations arising from this example are somewhat complex, particularly in view of the patterns of change of activity with time. They are presented in some detail to illustrate a number of the principles involved.
Biological assumptions. The assumptions set out below have been based on a number of sources and appear to be reasonable for a normal adult subject; pathology may lead to large variations in disappearance constants. These would result in lower blood and whole body doses.
The whole body has a mass of 70 kg, following the spleen, 176 g (Snyder et al., 1969) and the blood, 5.4 kg (ICRP, 1959) . The life span of the red cells (T) is 110 days and there is uniform labelling of cells of all ages. There are no random haemolytic processes. The chromium is eluted from the cells in an exponential fashion with a half-life of 70 days (biological disappearance constant /.q = 0.693/Tb = 0.010 d-1 ). The blood is distributed uniformly throughout the body.
Upon the death of the red cells, the fraction of the activity released which enters the spleen (f) is 0.6. Activity is lost from the spleen in an exponential manner with a biological half-life of27 days (,\ 2 = 0.026 d-1 ) and the released activity is rapidly eliminated from the body. The remainder of the activity arising from the destruction of red cells enters the liver and bone marrow, and its contribution to irradiation of the organs of interest is ignored.
Physical assumptions. The physical half-life of 51Cr is 28 days (decay constant,\= 0.025 d-1).
Values of Lli are taken from Dillman and Von der Lage (1975) or Appendix A. Values of¢ come from Snyder et al. (1969) . The activity in the spleen makes a small contribution to the absorbed dose to the whole body and vice versa. When considered in Table C -5 as source or target, the whole body, blood and spleen are represented by vw, VB and vs respectively. It is assumed that the absorbed dose to the blood resulting from gamma rays is equal to the mean absorbed dose to the whole body, but that the nonpenetrating radiation (x rays and Auger electrons) from circulating activity is confined to the blood.
Calculations. If there were no elution of chromium or physical decay, the proportion of initial activity remaining in the blood at a time t after administration would be (1 -ti r). The two exponential processes can be combined with this expression to give the activity remaining in the blood on day t
where A 0 is the initial activity. The time integral of the activity, Eq. (C.4-1), is plotted in Figure C .l (curve a) and As can be derived from the area under this curve. Alternatively, the integral may be evaluated analytically (McEwan, 1967) . Using the assumed values for the constants, AB = 21.5 A 0 Bq days = 1.86 X 10 6 A 0 Bq s.
Belcher and Hughes-Jones (1960) have shown that if there are no random haemolytic processes, the activity in the spleen at time t ( < r) is f Ao
and the time integral of the activity, As, is the integral of this expression from t = 0 to t = T.
Eq. (C.4-3) is plotted in Figure C.1 (curve b) . Once again, As can be derived from the area under the curve, or analytically, and for the assumed constants, As = 2.9 A 0 Bq d.
After time r, no more activity enters the spleen, and the combined physical and biological decay lead to the .7 x 10-11 7.9 x 10-12 5.5 x 10-11 2.6 x 10-10 5.5 x 10-11 3.2 x 10-10 5.8 x lo-10 1.1x10-9 5.5 x 10-11 1.7 x 10-9 D = (A/m)2:L1i¢i uptake in bone after intravenous or oral administration This example illustrates the method of calculating dose for a radionuclide having a radioactive daughter, and also the effect of radioisotope impurity: The effects of different degrees of assimilation from the gastrointestinal tract are also considered.
Biological assumptions. The skeleton is the organ of reference and has a mass of 10 kg. The uptake of calcium by bone from the blood stream is rapid and amounts to 90% of the activity present. Biological elimination is neglected. This assumption· is an over-simplification. In practice, the radionuclides are slowly removed from bone in a fairly complicated manner. Neglect of this process leads to an over-estimate of the dose, particularly for 4 5Ca. However, it is thought best to ignore this elimination in the present example, which serves toillustrate the methods of dealing with the data, rather than their veracity. All 47 Sc resulting from the decay of 4 7Ca deposited in bone remains in situ. The assimilation of scandium from the GI tract is negligible. Various levels of calcium assimilation are considered, e.g., (a) normal cases when administration is at high specific activity, (b) when large carrier quantities of calcium are added or (c) when malabsorption is present. The distributions of radiocalcium in bone and of bone mineral in the skeleton are markedly nonuniform; here, however, only the mean absorbed dose to the whole organ is considered.
Physical assumptions. 47 Ca decays with a physical half-life of 4.5 days to the radioactive daughter 47 Sc, which has a half-life of 3.4 days. Initially the activity of 4 7Sc is zero, but it builds up until there is a transient equilibrium of activities. Thereafter the decay of the 47 Sc lags behind that of the 47 Ca. The relative proportions of the two radionuclides administered, therefore, depend on the time that has elapsed since chemical separation. Here the simplifying assumption is made that no scandium is present at the time of administration. As far as bone uptake is concerned, the discrimination against scandium renders this assumption largely TABLE C-6-Absorbed dose in bone for uniform distribution in bone of one becquerel of each of the radionuclides 47Ca, 4 7Sc, and 4 5Ca. valid whatever the previous fate of the 47 Ca, particularly for oral administrations. If, in a particular case, the amount of 47 Sc present at the time of administration is known and appreciable, the absorbed dose to bone arising from it can be calculated by using the uptake factor of 20%. As there is no biological elimination of 47 Ca from bone, the effective half-life is equal to the physical half-life and the mean life is 1.44 times this value, so that A = 1.44 X 1 X 4.5 X 24 X 3600 = 5.6 X 105 Bq s for each Bq initially present.
Calculations. The activity of a radioactive daughter, Ad, with a physical decay constant/](= 0.693/T) formed from a parent with decay constant a, is j3 Ad= Ap /]-a [exp(-at) -exp(-/]t)] (C.5-1) where t is the time after the start of the decay of the parent, of initial activity Ap. The time integral of the activity of the daughter is obtained by integrating this expression over an appropriate time interval. In the present case, when only physical decay is considered, that time is zero to infinity .. Over this interval, the value of the integral is simply 1/ a, so that A for 4 7Sc is the same as for 47 Ca, i.e., 5.6 X 10 5 Bq s for 1 Bq initially present. This identity becomes clear if it is considered that every calcium atom that decays produces a scandium atom sooner or later. If a finite period is considered, Eq. (C.5-1) has to be integrated over the appropriate limits.
47 Ca is always accompanied by some contaminating 45 Ca. The initial proportion may be 1-2% when the 47 Ca is first prepared, but it increases with time, as 45 Ca has a half-life of 165 days. For the present calculation the initial proportion of 45 Ca is assumed to be 5%. The mean life of the 45 Ca is 165 X 1.44 X 24 X 3600 sand the time integral to infinity of the initial activity, A= 2.0 X 10 7
Bq s for 1 Bq initially present. The energies of the radiations emitted by 47 Ca and 47 Sc were taken from Lederer et al. (1967) and it was assumed that the mean energy of the (3 particles was 1/3 of the maximum. The reader may find it instructive to repeat the calculation using the more recent data presented in Table A -4. The absorbed fractions for the skeleton are taken from Snyder et al. (1969) . These Monte Carlo calculations are invaluable for this tissue, as the distribution of bones in the body cannot be approximated by any of Table C -6 are made initially assuming that 1 Bq of each radionuclide is present within the organ of reference and then the appropriate physiological factors are applied. When allowance is made for the physiological and physical factors described above, the absorbed doses in bone for one becquerel 47 Ca administered are as follows:
Intravenous:
Oral:
3.6 x 10-9 x 0.9 1.6 x 10-9 x 0.9 2.8 X 10-s X 0.9 X 0.05 = 3.2 x 10-9 Gy = 1.4 x 10-9 Gy = 1.3 x 10-9 Gy 5.9 x 10-9 Gy
The doses resulting from oral administration of 1 Bq of 47 Ca are the product of those from intravenous administration and the appropriate gut assimilation factor, as follows:
Normal assimilation without 3.5 X 10-9 Gy carrier ( 60%) Assimilation with calcium carrier 1.8 X 10-9 Gy (30%) Malabsorption (15%) 8.9 X 10-10 Gy
Example 6: 123 1, 125 1, 131 ! or 132 ! in the thyroid gland The main interest in this example is in the effect of different decay rates upon the time integral of activity, in circumstances when uptake may not be rapid in comparison with physical decay.
Biological assumptions. Assimilation from the gastrointestinal tract is rapid and complete, so that the 4.4 x 10-10 .5.2 x 10-10 4.5 x 10-9 2.0 X 10 I 5.9 x 10-s 2.6 x 10-7 4.1 X 10 I 1.1x10-9 2.4 X 10-s 4.3 x 10-7 5.1 x 10 g 4 x 10-13 5.9 x 10-10 9.1 x 10-11 9.8 x 10-12 5.8 x 10-9 D = (A/m)2:Lli¢i calculations are valid for oral as well as intravenous administrations. The thyroid uptake of radioiodine rises to a maximum of about 30% of the administered activity at about 24 hours after administration. The content of the gland then drops slowly with a long biological halflife. The actual metabolic processes are complicated, but for our purposes this pattern can be represented sufficiently accurately by assuming that the activity, A(t), in the gland, expressed as a fraction F(t) of the activity administered, A 0 , can be represented by
-exp(-;\ 1 t)] exp(-;\t) (C.6-1) ;\ 1 = biological disappearance constant for removal of activity from blood to the gland ;\ 2 = biological disappearance constant for removal of activity from gland ;\ = physical decay constant of the radionuclide Fm = value of F(t) obtained by extrapolating back to zero time the exponential final part of the curve showing activity against time t = time after administration.
For euthyroid subjects, the values Fm = 0.3, ;\ 1 = 4 d-1 , ;\ 2 = 0.01 d-1 are reasonable.
Radioiodine not taken up by the thyroid gland is removed by the kidneys. The radiation dose to other tissues is small compared with the dose of the thyroid gland, and the contributions to thyroid dose from extra-thyroidal activity are ignored.
As indicated in Appendix D, the distribution of radioiodine in the thyroid gland is markedly nonuniform, and for low-energy radiation the resulting dose distribution is heterogeneous. However, this effect is ignored in these calculations, mean absorbed dose only being considered.
Physical assumptions. Energies and abundances of the radiations are taken from Appendix A, grouped values of .1 being used to illustrate this concept. Absorbed fractions and mass are from Snyder et al. (1969) and physical half-lives from Dillman (1969) and Dillman (1970) .
Calculations. Values of the fraction F(t) (Eq. (C.6-1)) are plotted in Figure C For an administration of 1 Bq the value of A for each of the isotopes is: 12 3I 1.52 X 10 4 Bq s ( T 11 2 = 13 h) 12 s1 1.19 X 106 Bq s (T 1 ;2 = 60 d) 1 3 1 I 2.63 x 10 5 Bq s (T1;2 = 8 d) 1 3 2 I 1.27 X 103 Bq s (T 1 ;2 = 2.3 h).
While it is convenient to postulate a mathematical
Note 1
Readers should note that the tables given in MIRD Pamphlet No. 11 (Snyder et al., 1975 ) (referred to on pages 22 and 37 of this Report) can be used to reduce the labor involved in setting up a calculation of absorbed dose for a particular radiopharmaceutical that incorporates one of the radionuclides listed by Snyder et al. (1975) . This is accomplished by tabulating values of the absorbed dose per unit time integral of the activity, which is the dose rate per unit activity. This quantity, given the symbol S in the MIRD pamphlets, is tabulated for 20 source organs and 20 target organs for 117 radionuclides. Examples of the use of the tables are given in the pamphlet, but the authors stress that readers must "become familiar with the assumptions and limitations of the tables" before any calculations are made using them. model as above, and to derive the cumulated activity by integration, it is by no means essential. An uptake curve could be obtained from measurements on a number of subjects, the appropriate physical decay factors applied to successive points and the resulting curves plotted as in Figure C .2. The time integral of the activity could then be measured as the areas under the curves, at least for the rapidly decaying radioisotopes.
It can be seen from Figure C .2 that much of the activity of 12 31 and 132 1 has decayed before the biological peak is reached. For 125 1, and to a lesser extent for 131 I, there is little loss of accuracy if it is assumed that thyroid uptake is instantaneous and that there is subsequently an exponential decay combining physical decay and_th_e biological elimination postulated in Eq. (C.6-1) with biological half-life, 69 days. For 123 1 such an assumption leads to an overestimate of absorbed dose by a factor of 1.2, and for 132 1 the factor is 2.8.
The steps and results of the dose calculations are set out in Table C -7.
Note2
The results of calculations of absorbed dose in SI are expressed, in the above examples, in Gy for 1 Bq administered,. If expressed in mGy for 1 MBq administered, a factor of 10 9 is introduced and it may then be unnecessary to use exponential notation in presenting the final results. Thus, for example, in Table C-2 the absorbed dose to the liver becomes 0.089 mGy for 1 MBq administered, or 1/3.7 of the numerical value 0.33 mrad for 1 µCi administered, given in Table C-3. 
